Compare Koninklijke Philips NV (PHG) vs Raytheon Technologies Corp (RTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Raytheon Technologies Corp — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Raytheon Technologies Corp trades at $195.23 (market cap $260.81B). The key difference: Raytheon Technologies Corp is far larger — about 10.1× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| PHG | RTX | |
|---|---|---|
Market Cap | $25.89B | $260.81B |
Sector | Health | Industrials |
52-Week High | $32.91 | $212.16 |
52-Week Low | $25.02 | $149.17 |
Enterprise Value | $32.18B | $292.93B |
Dividend Yield | 3.81% | 1.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
RTX trades at $194.44, up 0.48% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.78 surpassing the $1.51 estimate. Revenue growth accelerated to $88.6B in 2025, and operating cash flow improved significantly to $10.57B. Recent contract wins, including a $515 million U.S. Navy radar award (PRNewsWire, June 3, 2026), underscore robust defense demand.
The outlook is positive, driven by multi-year defense agreements and expanding profit margins, though elevated debt levels and geopolitical risks pose challenges. Analyst consensus is strongly bullish with 18 buy ratings and no sells, supporting upside potential amid solid fundamental momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Raytheon Technologies Corp
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →
